DMAC: the cash flow

MyFinsight

For the year ending 2025-12-31, DMAC had $12,622K increase in cash & cash equivalents over the period. -$29,102K in free cash flow.

Cash Flow	2025-12-31
Total operating expenses, excluding share-based compensation	30,551
Research And Development Expense	1,320
General And Administrative Expense	2,526
Total share-based compensation	3,846
Operating loss	-34,397
Interest income	1,669
Other expense, net	10
Income tax expense	28
Net loss	-32,766
Share-based compensation	3,846
Amortization of discounts on marketable securities	942
Non-cash lease expense	82
Depreciation	43
Prepaid expenses and other assets	254
Amounts receivable	22
Deposits	-1,308
Accounts payable	535
Accrued liabilities	-892
Net cash used in operating activities	-29,062
Purchase of marketable securities	59,278
Maturities and sales of marketable securities	57,126
Purchase of property and equipment	40
Net cash provided by (used in) investing activities	-2,192
Proceeds from the sale of common shares, net of offering costs	43,282
Proceed from the exercise of common stock options	1,004
Principal payments on finance lease obligations	10
Deferred financing costs, net	400
Net cash provided by financing activities	43,876
Net increase (decrease) in cash and cash equivalents	12,622
Cash and cash equivalents at beginning of period	3,025
Cash and cash equivalents at end of period	15,647

Unit: Thousand (K) dollars (except for numbers of shares and EPS).